Genetic and Genomic Dissection of Psoriatic Arthritis
银屑病关节炎的遗传学和基因组解析
基本信息
- 批准号:10668441
- 负责人:
- 金额:$ 58.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-12 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesAreaArthritisAutoimmuneAutoimmune DiseasesBehaviorBiochemicalBloodBlood BanksBlood specimenCD8B1 geneCardiovascular DiseasesCellular AssayChronic small plaque psoriasisClinicClinicalClustered Regularly Interspaced Short Palindromic RepeatsCodeCollaborationsCollectionCutaneousDNADataDedicationsDermatologyDissectionElementsExhibitsGenesGeneticGenetic LoadGenetic MarkersGenetic studyGenomicsGenotypeHLA-C AntigensHealthHospitalsImmunityIn VitroIndividualInflammatoryInterferonsInternationalLifeLongitudinal cohortMachine LearningMemoryMessenger RNAMeta-AnalysisMichiganMicroRNAsModelingMutagenesisOsteoblastsOsteoclastsPathogenesisPatientsPredispositionProteinsPsoriasisPsoriatic ArthritisRNARegulatory ElementRegulatory T-LymphocyteResearchResourcesRheumatologyRiskRoleSTAT3 geneSamplingSerumSignal TransductionSiteSkinSmall Interfering RNAT-LymphocyteTNFSF15 geneTYK2TestingTranscriptUnited StatesUntranslated RNAVariantarthropathiesbiomarker developmentbiomarker identificationcausal variantclinically relevantcohortcomorbiditydifferential expressionexomefollow-upgenetic variantgenome wide association studyhigh riskinnovationinsightmemory CD4 T lymphocytemetabolomemetabolomicsnovelosteoblast differentiationpredictive markerrare variantrecruitsystemic autoimmunitytooltool developmenttranscriptometranscriptome sequencing
项目摘要
Psoriatic arthritis (PsA) is distinctive amongst the inflammatory/autoimmune joint diseases in that its onset
is commonly preceded by cutaneous psoriasis (PsC). This provides an unparalleled opportunity for the
identification of predictive biomarkers to determine which of the approximately 25% of psoriasis vulgaris (PsV)
patients will develop PsA. Over the past decade, we have expanded our genetic study of PsV to focus on PsA,
resulting in the collection of 1,279 PsA patients at Michigan, 743 of whom have already been subjected to
GWAS. Initiated in 2007, the International Psoriatic Arthritis Research Team (IPART) has accumulated 1,919
Canadian PsA patients, of whom 1,370 have already been subjected to GWAS. In 2015, we completed a meta-
GWAS of PsC and PsA involving a discovery cohort of 1,430 PsA cases and 1,417 controls, with 9,293
additional PsV replication samples (3,061 PsA, 3,110 PsC) and 13,670 controls. We detected 10 associations
for PsA and 11 for PsC, as well as a new association for PsV. Utilizing an innovative core exome array to
genotype additional cases and controls, we carried out the largest meta-GWAS of PsV to date (~40,000
subjects) and found 16 more susceptibility regions, highlighting the roles of interferon signaling and the NFB
cascade, and demonstrating strong enrichment for psoriasis genetic signals in T-cell regulatory elements.
Using machine learning to model ~200 genetic variants in our PsA vs. PsC GWAS, we achieved 82% area
under receiver operator curve for distinguishing PsA vs PsC, with 98% accuracy among the top 10% of
patients with the highest genetic load. We also carried out RNA-seq on mRNA and miRNA from 65 pairs of
pre- and post-conversion samples from PsC patients who developed PsA. Suggestive of a shift from skin-
focused to systemic autoimmunity, we found significant post-conversion enrichment for central memory CD4+
T-cell (CD4-Tcm) transcripts among the up-regulated genes. We also observed highly correlated pre- and post-
conversion behaviors of 54 differentially-expressed miRNAs and their mRNA targets, as well as multiple serum
miRNAs that are significantly differentially expressed in PsA vs. PsC. A metabolomic study of 50 paired
converter sera revealed 293 biochemicals with significant alterations, 275 of which were increased. Finally, we
identified noncoding eQTLs for IL23R that correlate strikingly with a region of selective PsA association.
Based on these results, we hypothesize that PsA and PsC have pathogenetic mechanisms that are T-cell,
osteoblast and osteoclast-driven and progress from skin to systemic during transition to PsA. We propose that
this paradigm can be used to develop a useful test to predict PsA in PsC patients, while increasing our basic
understanding of PsA. To test this hypothesis, we propose four aims: (1) to maintain and grow our longitudinal
clinical resource; (2) To identify biomarkers for the development of PsA in PsC patients; (3) To integrate the
biomarkers identified in Aim 2 into a clinically-useful tool for PsA identification using machine learning ; and (4)
to explore the mechanisms by which the IL23R gene contributes to PsA pathogenesis.
银屑病关节炎 (PsA) 在炎症/自身免疫性关节疾病中具有独特性,因为它的发病
通常先有皮肤牛皮癣(PsC)。这为
识别预测生物标志物,以确定大约 25% 的寻常型银屑病 (PsV) 中的哪一种
患者会发展为银屑病关节炎(PsA)。在过去的十年中,我们扩大了 PsV 的基因研究,重点关注 PsA,
密歇根州收集了 1,279 名 PsA 患者,其中 743 人已经接受过治疗
GWAS。国际银屑病关节炎研究小组 (IPART) 自 2007 年发起以来,已累计 1,919
加拿大银屑病关节炎患者,其中 1,370 名患者已经接受了 GWAS。 2015年,我们完成了元
PsC 和 PsA 的 GWAS 涉及 1,430 例 PsA 病例和 1,417 例对照的发现队列,其中 9,293 例
额外的 PsV 复制样本(3,061 个 PsA、3,110 个 PsC)和 13,670 个对照。我们检测到 10 个关联
针对 PsA 的关联和针对 PsC 的 11 关联,以及针对 PsV 的新关联。利用创新的核心外显子组阵列
对其他病例和对照进行基因分型,我们进行了迄今为止最大规模的 PsV 元 GWAS(约 40,000
受试者)并发现了另外 16 个易感区域,强调了干扰素信号传导和 NF+B 的作用
级联反应,并证明 T 细胞调节元件中银屑病遗传信号的强烈富集。
使用机器学习对 PsA 与 PsC GWAS 中的约 200 个遗传变异进行建模,我们获得了 82% 的面积
在接受者操作曲线下区分 PsA 与 PsC,准确率在前 10% 中达到 98%
遗传负荷最高的患者。我们还对 65 对 mRNA 和 miRNA 进行了 RNA-seq
来自患有 PsA 的 PsC 患者的转化前和转化后样本。暗示从皮肤的转变-
专注于系统性自身免疫,我们发现中央记忆 CD4+ 转换后显着富集
T 细胞 (CD4-Tcm) 在上调基因中转录。我们还观察到前后高度相关
54个差异表达的miRNA及其mRNA靶标以及多种血清的转化行为
PsA 与 PsC 中表达显着差异的 miRNA。 50对配对的代谢组学研究
转化者血清显示 293 种生化物质发生显着改变,其中 275 种生化物质有所增加。最后,我们
鉴定出 IL23R 的非编码 eQTL 与选择性 PsA 关联区域显着相关。
基于这些结果,我们假设 PsA 和 PsC 的发病机制是 T 细胞、
成骨细胞和破骨细胞驱动,并在向 PsA 转变期间从皮肤进展到全身。我们建议
该范式可用于开发一种有用的测试来预测 PsC 患者的 PsA,同时增加我们的基础知识
对 PSA 的了解。为了检验这一假设,我们提出四个目标:(1)维持和发展我们的纵向
临床资源; (2) 确定 PsC 患者发生 PsA 的生物标志物; (3) 整合
将目标 2 中确定的生物标志物转化为使用机器学习识别 PsA 的临床有用工具;和(4)
探讨 IL23R 基因促进 PsA 发病的机制。
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
MicroRNA-155 Controls iNKT Cell Development and Lineage Differentiation by Coordinating Multiple Regulating Pathways.
- DOI:10.3389/fcell.2020.619220
- 发表时间:2020
- 期刊:
- 影响因子:5.5
- 作者:Wang J;Li K;Zhang X;Li G;Liu T;Wu X;Brown SL;Zhou L;Mi QS
- 通讯作者:Mi QS
Dual Role of Act1 in Keratinocyte Differentiation and Host Defense: TRAF3IP2 Silencing Alters Keratinocyte Differentiation and Inhibits IL-17 Responses.
- DOI:10.1016/j.jid.2016.12.032
- 发表时间:2017-07
- 期刊:
- 影响因子:0
- 作者:Lambert S;Swindell WR;Tsoi LC;Stoll SW;Elder JT
- 通讯作者:Elder JT
RNA-Seq Analysis of IL-1B and IL-36 Responses in Epidermal Keratinocytes Identifies a Shared MyD88-Dependent Gene Signature.
- DOI:10.3389/fimmu.2018.00080
- 发表时间:2018
- 期刊:
- 影响因子:7.3
- 作者:Swindell WR;Beamer MA;Sarkar MK;Loftus S;Fullmer J;Xing X;Ward NL;Tsoi LC;Kahlenberg MJ;Liang Y;Gudjonsson JE
- 通讯作者:Gudjonsson JE
Endogenous Glucocorticoid Deficiency in Psoriasis Promotes Inflammation and Abnormal Differentiation.
- DOI:10.1016/j.jid.2017.02.972
- 发表时间:2017-07
- 期刊:
- 影响因子:0
- 作者:Sarkar MK;Kaplan N;Tsoi LC;Xing X;Liang Y;Swindell WR;Hoover P;Aravind M;Baida G;Clark M;Voorhees JJ;Nair RP;Elder JT;Budunova I;Getsios S;Gudjonsson JE
- 通讯作者:Gudjonsson JE
Proprotein convertase subtilisin/kexin type 9 is a psoriasis-susceptibility locus that is negatively related to IL36G.
普罗蛋白转化酶枯草蛋白/KEXIN 9型是牛皮癣敏感性基因座,与IL36G负相关。
- DOI:10.1172/jci.insight.141193
- 发表时间:2022-08-22
- 期刊:
- 影响因子:8
- 作者:Merleev, Alexander;Ji-Xu, Antonio;Toussi, Atrin;Tsoi, Lam C.;Le, Stephanie T.;Luxardi, Guillaume;Xing, Xianying;Wasikowski, Rachael;Liakos, William;Brueggen, Marie-Charlotte;Elder, James T.;Adamopoulos, Iannis E.;Izumiya, Yoshihiro;Leal, Annie R.;Li, Qinyuan;Kuzminykh, Nikolay Y.;Kirane, Amanda;Marusina, Alina, I;Gudjonsson, Johann E.;Maverakis, Emanual
- 通讯作者:Maverakis, Emanual
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES TILFORD ELDER其他文献
JAMES TILFORD ELDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES TILFORD ELDER', 18)}}的其他基金
Genetic and Genomic Dissection of Psoriatic Arthritis
银屑病关节炎的遗传学和基因组解析
- 批准号:
8543630 - 财政年份:2012
- 资助金额:
$ 58.61万 - 项目类别:
Genetic and Genomic Dissection of Psoriatic Arthritis
银屑病关节炎的遗传学和基因组解析
- 批准号:
10439764 - 财政年份:2012
- 资助金额:
$ 58.61万 - 项目类别:
Genetic and Genomic Dissection of Psoriatic Arthritis
银屑病关节炎的遗传学和基因组解析
- 批准号:
10208711 - 财政年份:2012
- 资助金额:
$ 58.61万 - 项目类别:
Genetic and Genomic Dissection of Psoriatic Arthritis
银屑病关节炎的遗传学和基因组解析
- 批准号:
8712139 - 财政年份:2012
- 资助金额:
$ 58.61万 - 项目类别:
Genetic and Genomic Dissection of Psoriatic Arthritis
银屑病关节炎的遗传学和基因组解析
- 批准号:
9125725 - 财政年份:2012
- 资助金额:
$ 58.61万 - 项目类别:
Genetic and Genomic Dissection of Psoriatic Arthritis
银屑病关节炎的遗传学和基因组解析
- 批准号:
8400592 - 财政年份:2012
- 资助金额:
$ 58.61万 - 项目类别:
Genetic and Genomic Dissection of Psoriatic Arthritis
银屑病关节炎的遗传学和基因组解析
- 批准号:
10017154 - 财政年份:2012
- 资助金额:
$ 58.61万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 58.61万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 58.61万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 58.61万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 58.61万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 58.61万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 58.61万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 58.61万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 58.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 58.61万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 58.61万 - 项目类别:














{{item.name}}会员




